Across TCGA pan-cancer cohorts, MIR30D Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR30D data layer compared with 8 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR30D Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR30D expression acts as an unfavorable survival marker.

HNSC are the cancer types where MIR30D Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.151	0.685	.007	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR30D tumor-vs-normal RNA expression · all MIR30D data types